Abstract
We read with interest the article by Chimenti and Frustaci1 on the advantages and disadvantages of the left ventricular (LV) endomyocardial biopsy (EMB) for the investigation of cardiomyopathies in comparison with the use of the right ventricular biopsy. The authors concluded that the risk of major complications from LV EMB was <1% and that its diagnostic performance was superior to those obtained from right ventricular EMB in patients with cardiomyopathies and clinically preserved right ventricles. This article raises the global question of the use of EMB in the daily management of patients with acute or chronic cardiomyopathies. Besides the unequivocal value of EBM in clinical investigations and in monitoring rejection after heart transplantation, its use for the …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
